Physician

Mazen Khattab, MD

According to 2025 Medicare claims, Mazen Khattab, MD (NPI: 1205804283) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL GROUP OF ARIZONA LLC (NPI: 1609026806; TIN: 320260988) and primary practice location at 85027-3127. Khattab is affiliated with the Banner Health Network (ACO ID: A3229), participating under the MSSP model.

Khattab's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,492 traditional Medicare patients, billed 216,759 HCPCS/CPT codes, and received $4,237,373 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,378 prescription claims across 382 beneficiaries totaling $2,685,092 in drug costs, led by Iclusig (Ponatinib Hcl). DME data shows 71 claims. Open Payments data shows 231 records totaling $8,778. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,787,833 and ending at $4,237,373. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,068,253 and ending at $2,685,092. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	553	201,412	$1,787,833
2016	540	217,106	$2,646,050
2017	595	178,836	$2,143,848
2018	626	189,096	$2,190,997
2019	678	172,497	$2,266,857
2020	650	163,659	$2,518,774
2021	435	101,034	$1,386,557
2022	556	151,630	$2,305,916
2023	661	143,913	$2,695,642
2024	1,492	216,759	$4,237,373

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	257	2,092	$1,068,253
2016	304	2,594	$2,811,759
2017	346	2,499	$3,065,362
2018	349	1,982	$3,404,420
2019	359	1,915	$4,281,835
2020	370	1,950	$4,676,376
2021	310	1,277	$1,734,747
2022	310	1,484	$2,530,893
2023	319	1,518	$3,305,903
2024	382	1,378	$2,685,092

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	161	$46,795
2016	N/R	110	$38,986
2017	N/R	N/R	N/R
2018	N/R	13	$3,971
2019	N/R	36	$5,068
2020	N/R	26	$3,639
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	71	$1,872

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	413	915	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	354	488	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	355	439	$13
36415	Insertion of needle into vein for collection of blood sample	1,329	4,054	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,333	5,138	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Iclusig	Ponatinib Hcl	12	360	$256,887
Verzenio	Abemaciclib	16	448	$247,756
Nubeqa	Darolutamide	17	510	$227,749
Lynparza	Olaparib	13	390	$216,317
Eliquis	Apixaban	189	6,882	$132,564

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	31	$1,308
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	24	$301
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	231	$8,778	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mazen Khattab, MD?

Tedicare shows public-source Medicare data for Mazen Khattab, MD (NPI 1205804283), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mazen Khattab, MD have ACO affiliation data?

Mazen Khattab, MD is shown with ACO affiliation data for Banner Health Network (MSSP, ACO ID A3229).

What billing organization is linked to Mazen Khattab, MD?

Mazen Khattab, MD is linked to CITY OF HOPE MEDICAL GROUP OF ARIZONA LLC (billing NPI 1609026806) in the available physician profile data.

Does Mazen Khattab, MD have Open Payments data?

Mazen Khattab, MD has 231 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.